Fast forward for systemic lupus erythematosus clinical trials

被引：1
|
作者：
Crow, Mary K. [1 ,2 ]
机构：
[1] Benjamin M Rosen Chair Immunol & Inflammat Res, New York, NY USA
[2] Hosp Special Surg, New York, NY 10021 USA
来源：
NATURE CLINICAL PRACTICE RHEUMATOLOGY | 2008年 / 4卷 / 08期
关键词：
D O I：
10.1038/ncprheum0866
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：387 / 387
页数：1
相关论文
共 50 条
  • [31] Randomized Clinical Trials of Systemic Lupus Erythematosus: Evaluating Differences in the Enrolled Populations
    Goel, Niti
    Barrett, Brandon
    Duncan, Ann
    Gallagher, Margaret-Beth
    Mackey, Marsha
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [32] Population pharmacokinetics of atacicept in systemic lupus erythematosus: An analysis of three clinical trials
    Pitsiu, Maria
    Yalkinoglu, Oezkan
    Farrell, Colm
    Girard, Pascal
    Vazquez-Mateo, Cristina
    Papasouliotis, Orestis
    [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2023, 12 (08): : 1157 - 1169
  • [33] Belimumab: a step forward in the treatment of systemic lupus erythematosus
    Depascale, Roberto
    Gatto, Mariele
    Zen, Margherita
    Saccon, Francesca
    Larosa, Maddalena
    Zanatta, Elisabetta
    Bindoli, Sara
    Doria, Andrea
    Iaccarino, Luca
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (05) : 563 - 573
  • [34] CLINICAL DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS
    ARMASCRUZ, R
    HARNECKER, J
    DUCACH, G
    JALIL, J
    GONZALEZ, F
    [J]. AMERICAN JOURNAL OF MEDICINE, 1958, 25 (03): : 409 - 419
  • [35] Systemic lupus erythematosus: Clinical presentations
    Smith, Paul P.
    Gordon, Caroline
    [J]. AUTOIMMUNITY REVIEWS, 2010, 10 (01) : 43 - 45
  • [36] Systemic lupus erythematosus: a clinical update
    Connelly, Kathryn
    Morand, Eric F.
    [J]. INTERNAL MEDICINE JOURNAL, 2021, 51 (08) : 1219 - 1228
  • [37] THE CLINICAL COURSE OF SYSTEMIC LUPUS ERYTHEMATOSUS
    TUMULTY, PA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1954, 156 (10): : 947 - 953
  • [38] Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index
    Kalunian, Kenneth C.
    Urowitz, Murray B.
    Isenberg, David
    Merrill, Joan T.
    Petri, Michelle
    Furie, Richard A.
    Morgan-Cox, Mary-Ann
    Taha, Rebecca
    Watts, Steven
    Silk, Maria
    Linnik, Matthew D.
    [J]. RHEUMATOLOGY, 2018, 57 (01) : 125 - 133
  • [39] Endpoints for randomised controlled trials in systemic lupus erythematosus
    Aringer, M.
    Strand, V.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (02) : 147 - 151
  • [40] Biomarkers, surrogate markers, and design of clinical trials of new therapies for systemic lupus erythematosus
    Schiffenbauer, J
    Hahn, B
    Weisman, MH
    Simon, LS
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (08): : 2415 - 2422
12345